Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-11-21

FDA Approved: LEFLUNOMIDE — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a generic Leflunomide product from Alembic Pharmaceuticals Limited under an original ANDA for the treatment of rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leflunomide (Leflunomide)

Snippet

ORIG AP for LEFLUNOMIDE (LEFLUNOMIDE)